Saidu College of dentistry,Swat
Swat, Pakistan
NCT Number: NCT07271654
This randomized controlled trial investigated whether a single dose of diclofenac sodium taken before a root canal procedure can reduce pain in the hours following the treatment. 160 patients with tooth pain from irreversible pulpitis were divided into two groups. One group received 100mg of diclofenac sodium 30 minutes before their procedure, while the other group received no pretreatment. Pain levels were measured at 6, 12, and 24 hours after the procedure. The study found that patients who took diclofenac before treatment were significantly more likely to be pain-free at 6 and 12 hours after the procedure compared to those who did not.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Swat, Pakistan
This was a parallel-arm, randomized controlled trial conducted in the Department of Operative Dentistry, Saidu College of Dentistry. A total of 160 patients aged 20-60 years with a diagnosis of irreversible pulpitis in vital teeth were enrolled via consecutive sampling. Participants were randomized using a computer-generated sequence with allocation concealment via sealed opaque envelopes. The experimental group (n=80) received a single oral dose of 100 mg diclofenac sodium 30 minutes prior to endodontic treatment. The control group (n=80) received no pretreatment medication. All endodontic treatments were performed by experienced operators using a standardized protocol. The primary outcome was postendodontic pain intensity, assessed using a Visual Analogue Scale (VAS) and categorized as none, mild, moderate, or severe. Pain levels were recorded via structured telephone interviews at 6, 12, and 24 hours post-treatment. Statistical analysis was performed using R software, with group comparisons made using the chi-square test.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Pakistani nationals aged 20-60 years. Diagnosis of irreversible pulpitis in a vital tooth (single or multi-rooted), confirmed by a positive cold test.
No evidence of periapical abscess on radiographs. - Exclusion Criteria:Prior use of analgesics within a specified timeframe Presence of periodontal disease.
Current use of prophylactic antibiotics.
Pregnancy or lactation.
Mental disabilities.
Systemic illnesses contraindicating endodontic therapy.
Known hypersensitivity or adverse reaction to NSAIDs.
-
Single oral dose of 100 mg Diclofenac Sodium, administered 30 minutes prior to endodontic treatment.
Single oral dose of 100 mg Diclofenac Sodium, administered 30 minutes prior to endodontic treatment.
Time frame: 6 hours after endodontic treatment
Proportion of patients reporting no pain, mild pain, moderate pain, or severe pain as measured on a Visual Analogue Scale (VAS
Time frame: 12 hours after endodontic treatment
Proportion of patients reporting no pain, mild pain, moderate pain, or severe pain as measured on a Visual Analogue Scale (VAS).
Time frame: 24 hours after endodontic treatment
Proportion of patients reporting no pain, mild pain, moderate pain, or severe pain as measured on a Visual Analogue Scale (VAS).
College of Physicians and Surgeons Pakistan
Other
Can Pretreatment With Analgesics Reduce Postendodontic Pain? A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07270159
Irreversible Pulpitis with Apical Periodontitis, Neurologic Manifestations
Karachi, Sindh, Pakistan
View Trial DetailsNCT06760312
Dental Pulp Diseases, Inflammation
Izmir, Çiğli, Turkey (Türkiye)
View Trial DetailsNCT06832254
Neurologic Manifestations, Pain
Adana, Sarıçam, Turkey (Türkiye)
View Trial DetailsNCT06820996
Neurologic Manifestations, Pain
Adana, Sarıçam, Turkey (Türkiye)
View Trial Details